Low-intensity pulsed ultrasound promotes peripheral nerve regeneration by alleviating Schwann cells pyroptosis Authors: Junfeng Chen, Lu Yu, Yansong Lu, Yufei Zhang, Cheng-kung Cheng, Yifei Yao Published: 2026 ABSTRACT Peripheral nerve injury (PNI), a common clinical condition, heavily relies on the functional condition of Schwann cells (SCs) for effective repair. Emerging evidence shows that excessive pyroptosis of SCs hinders neural regeneration. Low-intensity pulsed ultrasound (LIPUS), a non-invasive physical therapy, shows potential in tissue repair; however, its role in regulating SCs pyroptosis remains unclear. This study explores the mechanism by which LIPUS improves PNI recovery by reducing SCs pyroptosis. We find that LIPUS significantly enhances motor function recovery, promotes axonal regeneration and remyelination, and decreases gastrocnemius muscle atrophy through a rat sciatic nerve crush model. LIPUS biomechanically mitigates mitochondrial dysfunction in SCs, thereby suppressing the NLRP3/Caspase-1/GSDMD-N pyroptosis signaling pathway. This inhibition reduces IL-1β and IL-18 release, boosting SCs proliferation, migration, and clearance of myelin debris, collectively fostering a regenerative microenvironment that supports axonal regrowth, remyelination, and functional recovery. Our results demonstrate a mechanobiological mechanism by which LIPUS promotes peripheral nerve regeneration through alleviating pyroptosis, providing a promising therapeutic approach for PNI. Introduction Peripheral nerve injury (PNI) is a common debilitating condition, while peripheral nerve repair and regeneration are complex and inefficient processes, leading to persistent sensory and motor dysfunction in patients and placing a significant burden on social medical resources1. Schwann cells (SCs) in the peripheral nervous system play multiple regulatory roles in the PNI pathological process. In the acute phase of PNI, SCs clear myelin debris resulting from Wallerian degeneration by dedifferentiation and proliferation2–4. Subsequently, they form Büngner bands, providing a directional growth path for axonal regeneration5,6, and optimize the local microenvironment by secreting neurotrophic factors to promote axonal regeneration and myelin reconstruction7. Recent studies have shown that programmed cell death, especially pyroptosis, plays an important role in the pathological process after PNI8,9. Pyroptosis is a programmed lytic cell death mediated by inflammasome activation that is initiated by the activation of the NLRP3 inflammasome, recruiting apoptosis-associated speck-like protein (ASC) and activating Caspase-1, and then cleaving Gasdermin D (GSDMD) protein to generate the N-terminal fragment (GSDMD-N), which forms pores on the cell membrane, leading to cell osmotic swelling and rupture10–12. This process is accompanied by the release of pro-inflammatory factors such as IL-1β and IL-18, exacerbating the local inflammatory cascade13,14. Although moderate pyroptosis helps clear damaged cells, excessive pyroptosis of SCs can directly lead to a sharp reduction in the number of functional SCs, weakening their ability to clear myelin debris15 and hindering the formation of regeneration tracks (Büngner bands)9. This process can ultimately form a persistent pro-inflammatory microenvironment, hindering axonal regeneration and functional recovery. Therefore, targeted inhibition of SCs pyroptosis has become a promising strategy to promote nerve regeneration16–18. Low-intensity pulsed ultrasound (LIPUS), as a noninvasive therapeutic modality approved by the Food and Drug Administration, exploits its tissue penetration and biomechanical effects to demonstrate considerable potential in treating musculoskeletal disorders19–21. In the field of nerve repair, LIPUS has been reported to enhance the vitality and proliferation of SCs22, upregulate the secretion of neurotrophic factors23, and improve axonal regeneration and functional recovery in the PNI model5. Additionally, the anti-inflammatory property of LIPUS was also evidenced in a diabetic peripheral neuropathy model, where it significantly suppressed levels of the key inflammatory mediators IL-1β and IL-1824. Pyroptosis can be triggered by mitochondrial dysfunction, reactive oxygen species (ROS), and inflammatory cytokines9,25. After tissue injury, mitochondrial dysfunction frequently results in excessive mitochondrial ROS (mtROS) accumulation and loss of mitochondrial membrane potential (MMP), which in turn triggers NLRP3 inflammasome activation26,27. Despite these advances, it remains unclear whether LIPUS can alleviate SCsF pyroptosis by regulating mitochondrial dysfunction and NLRP3 inflammasome activation. Therefore, the aim of this study was to investigate how LIPUS suppresses the SCs pyroptosis both in vivo and in vitro, which led to reduced release of proinflammatory cytokines. We hypothesized that LIPUS enhances the viability, migration, and myelin debris clearance ability of SCs by alleviating the pyroptosis pathway and reducing the secretion of inflammatory factors, ultimately promoting peripheral nerve regeneration and functional recovery. Results LIPUS promotes the restoration of functional nerve innervation after PNI To assess the therapeutic potential of LIPUS at different stages after PNI, a rat sciatic nerve crush model was established. LIPUS was administered for 5 or 14 days to systematically evaluate motor function, nerve regeneration, and muscle reinnervation (Fig. 1a). Behavioral assessment revealed that the rat hind limbs in the PNI group exhibited typical denervation manifestations, including claw contracture and toe closure. In contrast, the LIPUS treatment group showed a more natural toe extension posture (Fig.1b). Further dynamic monitoring of the sciatic nerve function index (SFI) at 7 and 14 days post injury (dpi) demonstrated that the LIPUS group had significantly improved SFI values compared with the PNI group (Fig. 1c, d). Moreover, the PNI group rats developed ankle dorsiflexion contracture with a restricted range of motion, while LIPUS intervention significantly attenuated these secondary joint impairments (Fig. 1e, f).Fig. 1LIPUS promotes the restoration of functional nerve innervation after PNI.a Schematic diagram of the peripheral nerve injury (PNI) model and low-intensity pulsed ultrasound (LIPUS) treatment with regeneration evaluation. b Comparison of toe conditions in different groups at 14 dpi. c, d Representative footprints and Sciatic Functional Index (SFI). e, f Ankle range of motion (ROM) assessment at 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WSTOY406c7). LIPUS promotes the restoration of functional nerve innervation after PNI. a Schematic diagram of the peripheral nerve injury (PNI) model and low-intensity pulsed ultrasound (LIPUS) treatment with regeneration evaluation. b Comparison of toe conditions in different groups at 14 dpi. c, d Representative footprints and Sciatic Functional Index (SFI). e, f Ankle range of motion (ROM) assessment at 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WSTOY406c7). LIPUS promotes nerve regeneration after PNI To elucidate the effect of LIPUS on nerve regeneration, histological assessments were performed on the central region of the injured sciatic nerve (2 mm) at 5 and 14 dpi (Fig. 2a). Evaluation of myelin regeneration by Luxol fast blue (LFB) staining showed a significant increase in the number of myelin sheaths in the LIPUS treatment group compared to the PNI group (Fig. 2b–d). Morphological assessment further revealed a greater density of regenerated nerve fibers in the LIPUS group compared to the PNI group (Fig. 2e–h). In addition, immunological staining results revealed that expression levels of the myelin marker MBP and the axonal marker NF200 were significantly upregulated in the LIPUS group compared to the PNI group at 5 and 14 dpi (Fig. 2i–m). Collectively, these findings confirm that LIPUS promotes myelin formation and axonal regeneration after PNI.Fig. 2LIPUS promotes axonal and myelin regeneration after PNI.a Schematic diagram of histological analysis of sciatic nerve injur. b–d Luxol fast blue (LFB)-stained images and quantitative analysis of myelin sheath at 5 and 14 dpi. e–h Representative H&E and Masson’s staining images and quantitative analysis of sciatic nerve tissues at 5 and 14 dpi in different groups. i–m Representative immunohistochemistry (IHC) and Immunofluorescence (IF) images and quantification of NF 200 and MBP-positive in different groups at 5 dpi and 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. y. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WIPAT7fdf5). LIPUS promotes axonal and myelin regeneration after PNI. a Schematic diagram of histological analysis of sciatic nerve injur. b–d Luxol fast blue (LFB)-stained images and quantitative analysis of myelin sheath at 5 and 14 dpi. e–h Representative H&E and Masson’s staining images and quantitative analysis of sciatic nerve tissues at 5 and 14 dpi in different groups. i–m Representative immunohistochemistry (IHC) and Immunofluorescence (IF) images and quantification of NF 200 and MBP-positive in different groups at 5 dpi and 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. y. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WIPAT7fdf5). LIPUS alleviates gastrocnemius muscle atrophy after denervation Sciatic nerve injury typically leads to denervation atrophy of the innervated gastrocnemius muscle, and the functional recovery critically depends on the re-innervation of the target muscles. We analyzed the morphological and structural changes of the gastrocnemius muscle through wet weight, H&E staining, and Masson staining (Fig. 3a). Gastrocnemius muscles were harvested at 5 dpi and 14 dpi, respectively. The wet weight ratio of these muscles was measured, and the muscle fiber diameter and cross-sectional area were quantitatively analyzed. The results showed that compared with the PNI group, LIPUS treatment could significantly alleviate the progression of denervation atrophy, which was manifested by an increase in the muscle wet weight ratio and an increase in muscle fiber diameter and area (Fig. 3b–h). Furthermore, the collagen volume fraction was significantly lower in both the sham and the LIPUS group than that in the PNI group (Fig. 3i–k), indicating that LIPUS can effectively suppress fibrosis in denervated muscle.Fig. 3LIPUS alleviates gastrocnemius muscle atrophy after denervation.a Schematic diagram of muscle analysis after nerve injury and treatment at 5 and 14 dpi. b, c Macrographs of muscle and wet weight ratio. d–h Representative H&E-stained images and quantification of muscle fiber area and diameter in different groups at 5 and 14 dpi. i–k Representative Masson-stained images and quantification of collagen volume fraction in different groups at 5 and 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: AUUOW48328). LIPUS alleviates gastrocnemius muscle atrophy after denervation. a Schematic diagram of muscle analysis after nerve injury and treatment at 5 and 14 dpi. b, c Macrographs of muscle and wet weight ratio. d–h Representative H&E-stained images and quantification of muscle fiber area and diameter in different groups at 5 and 14 dpi. i–k Representative Masson-stained images and quantification of collagen volume fraction in different groups at 5 and 14 dpi. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: AUUOW48328). We further assess systemic toxicity through H&E staining on major organs, including the heart, liver, spleen, lungs, and kidneys. The results confirmed that LIPUS, as a mechanical force stimulus, does not cause adverse effects on major organs (Supplementary Fig. 1). LIPUS alleviates SCs pyroptosis in a rat PNI model To elucidate the molecular mechanism underlying LIPUS-mediated promotion of nerve regeneration after PNI, we performed RNA sequencing on sciatic nerve tissues from rat PNI models and LIPUS-treated models at 5 dpi (Fig. 4a). Transcriptomic analysis identified 1283 up-regulated genes and 1089 down-regulated genes (Fig. 4b, c). Gene Ontology (GO) enrichment analysis revealed that the up-regulated genes were significantly enriched in gliogenesis, axon ensheathment, ensheathment of neurons, myelination, peripheral nervous system axon ensheathment, myelination in the peripheral nervous system, and response to mechanical stimulus after LIPUS treatment. The down-regulated genes were significantly enriched in interleukin-1 beta production, positive regulation of canonical NF-κB signaling transduction, toll-like receptor signaling pathway, positive regulation of interleukin-1 beta production, pyroptosis, positive regulation of cytokine-mediated signaling pathway, and inflammasome-mediated signaling pathway (Fig. 4d, e). These transcriptomic features suggest that LIPUS, as a mechanical force stimulation, may effectively alleviate the inflammatory damage of neural tissues by activating the expression programs of genes related to myelin regeneration and by reducing inflammatory factors and the signaling pathways associated with cell pyroptosis.Fig. 4LIPUS alleviates SCs pyroptosis in a rat PNI model.a Schematic diagram of RNA sequencing analysis after nerve injury and treatment at 5 dpi. n = 3 animals. b, c Heatmap plot and volcano plot of differentially expressed genes between the sciatic nerve injury group and the LIPUS treatment group. d, e Gene Ontology (GO) analysis of RNA sequencing results. f–j Protein expression levels and quantitative results of Cleaved-Caspase-1, GSDMD-N, ASC, and NLRP3 in different groups. n = 3 animals. k Quantitative analysis of S100-positive expression in sciatic nerve tissues at 5 dpi. l–o Immunofluorescence (IF) staining and quantification of fluorescence intensities of NLRP3 and GSDMD-N positive in different groups. n = 6 animals. p, q Levels of IL-18 and IL-1β in sciatic nerve tissues across experimental groups were quantified using enzyme-linked immunosorbent assay (ELISA). n = 3 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: YPYWA2ed2e). LIPUS alleviates SCs pyroptosis in a rat PNI model. a Schematic diagram of RNA sequencing analysis after nerve injury and treatment at 5 dpi. n = 3 animals. b, c Heatmap plot and volcano plot of differentially expressed genes between the sciatic nerve injury group and the LIPUS treatment group. d, e Gene Ontology (GO) analysis of RNA sequencing results. f–j Protein expression levels and quantitative results of Cleaved-Caspase-1, GSDMD-N, ASC, and NLRP3 in different groups. n = 3 animals. k Quantitative analysis of S100-positive expression in sciatic nerve tissues at 5 dpi. l–o Immunofluorescence (IF) staining and quantification of fluorescence intensities of NLRP3 and GSDMD-N positive in different groups. n = 6 animals. p, q Levels of IL-18 and IL-1β in sciatic nerve tissues across experimental groups were quantified using enzyme-linked immunosorbent assay (ELISA). n = 3 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: YPYWA2ed2e). To further investigate the role of SCs pyroptosis in the early regenerative process following PNI, we assessed the expression of pyroptosis-related proteins at 5 dpi. Western blot analysis revealed significantly increased expression of Cleaved-Caspase-1, GSDMD-N, ASC, and NLRP3 following PNI. Concurrently, LIPUS intervention effectively inhibited the expression of these proteins (Fig. 4f–j). Immunofluorescence staining corroborated these findings, showing significantly increased expression of pyroptosis markers NLRP3 and GSDMD-N in the PNI group that was significantly reversed by LIPUS treatment (Fig. 4l–o). LIPUS treatment also reversed the injury-induced decrease in the SCs marker S100, indicating an increase in SCs numbers (Fig. 4k). Additionally, enzyme-linked immunosorbent assay (ELISA) measurements of inflammatory cytokine levels in sciatic nerve tissue revealed that LIPUS treatment significantly reduced the release of IL-1β and IL-18 (Fig. 4p, q). Macrophages play a critical regulatory role in the early regenerative microenvironment following PNI9,28,29. Our study further investigated the regulatory effect of LIPUS on macrophage pyroptosis. Immunofluorescence analysis revealed that macrophages at the injury site exhibited elevated expression of pyroptosis markers at 5 dpi, whereas LIPUS significantly reduced this expression (Supplementary Fig. 2a, b). Further analysis of macrophage polarization status indicated a lower number of pro-inflammatory M1 macrophages and a significantly higher number of anti-inflammatory M2 macrophages in the LIPUS group (Supplementary Fig. 2c, d). These findings indicated that LIPUS can promote a phenotypic switch of macrophages from a pro-inflammatory toward a pro-repair state, thereby attenuating the inflammatory microenvironment and creating a more favorable microenvironment for the functional recovery of SCs. LIPUS promotes SCs-mediated myelin debris clearance Wallerian degeneration occurs in the distal nerve segment following PNI, leading to the generation of myelin debris. Timely clearance of this debris during the early stages of injury is a critical prerequisite for axonal regeneration3. To investigate whether LIPUS promotes this process, we first assessed residual myelin in vivo using Oil Red O (ORO) staining. Substantial accumulation of myelin degradation products was observed in the PNI group at 5 dpi, and LIPUS treatment significantly reduced this residue (Fig. 5a, b). To further investigate the role of LIPUS-mediated SCs clearance of myelin debris, we used immunofluorescence staining to label dedifferentiated SCs (GFAP) and myelin (MPZ) separately and analyzed their co-localization. In the sham group, myelin structure remained intact with uniform MPZ distribution. In contrast, the PNI group exhibited fragmented MPZ distribution surrounded by dedifferentiated SCs. Notably, LIPUS intervention effectively reduced the number of abnormal myelin fragments (Fig. 5c, d).Fig. 5LIPUS promotes SCs-mediated myelin debris clearance.a, b Longitudinal sections of sciatic nerves from different groups stained with Oil Red O (ORO) for myelin debris at 5 dpi. n = 6 animals. c, d Immunofluorescence (IF) images and quantitative analysis of MPZ and GFAP-positive expression in sciatic nerve tissues at 5 dpi. e Representative images of myelin debris clearance by SCs with or without LIPUS treatment at 12 h, 24 h, and 48 h. f Schematic diagram of SCs clearing myelin debris in vitro. g Quantitative analysis of myelin debris clearance by SCs with or without LIPUS treatment at 12 h, 24 h, and 48 h. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WISWPc8cb5). LIPUS promotes SCs-mediated myelin debris clearance. a, b Longitudinal sections of sciatic nerves from different groups stained with Oil Red O (ORO) for myelin debris at 5 dpi. n = 6 animals. c, d Immunofluorescence (IF) images and quantitative analysis of MPZ and GFAP-positive expression in sciatic nerve tissues at 5 dpi. e Representative images of myelin debris clearance by SCs with or without LIPUS treatment at 12 h, 24 h, and 48 h. f Schematic diagram of SCs clearing myelin debris in vitro. g Quantitative analysis of myelin debris clearance by SCs with or without LIPUS treatment at 12 h, 24 h, and 48 h. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: WISWPc8cb5). To directly assess the effect of LIPUS on the phagocytic activity of SCs, we incubated SCs with extracted myelin debris and applied LIPUS in vitro. Immunofluorescence staining showed that after 24 h of co-incubation of myelin debris with SCs, a large number of MBP-positive signals were observed within the SCs. However, the MBP fluorescence intensity in cells treated with LIPUS was reduced at 12 h, 24 h, and 48 h, indicating accelerated degradation of myelin debris (Fig. 5e–g). These results collectively demonstrate that LIPUS can significantly enhance the phagocytic and clearance efficiency of SCs for myelin debris, thereby creating a regenerative microenvironment for axonal regeneration. To determine the contribution of macrophages to early myelin clearance, an in vivo model of specific macrophage depletion was used via clodronate liposomes (CL). At 5 dpi, we assessed macrophage presence and myelin debris clearance (Supplementary Fig. 3a). The results showed that CL treatment significantly reduced CD68-positive macrophages in the liver, spleen, and sciatic nerve tissues (Supplementary Fig. 3b–e). However, staining for myelin debris (ORO and MPZ immunofluorescence) showed that macrophage depletion did not reduce the amount of myelin debris after PNI. Notably, LIPUS treatment still significantly reduced myelin debris accumulation even under conditions of macrophage deficiency (Supplementary Fig. 3f–h), indicating that macrophages are not the primary effectors for myelin debris clearance in the early phase following PNI. Macrophages contribute to the regeneration process after PNI To further elucidate the role of macrophages in remyelination and axonal regeneration during the early phase after PNI, we conducted analyses using a macrophage depletion model. The results revealed that macrophage depletion led to a significant downregulation of the regenerative markers NF 200 and MBP. This finding was corroborated by LFB staining, which confirmed a decrease in myelin quantity. LIPUS treatment effectively reversed these inhibitory effects, enhancing neural regeneration markers even in the absence of macrophages (Supplementary Fig. 4), underscoring a supportive role for macrophages in the early regenerative microenvironment. LIPUS promotes the viability of LPS + ATP-induced SCs in vitro Based on established models in which SCs pyroptosis was induced by LPS + ATP treatment8,18, we assessed the inhibitory effect of LIPUS on pyroptosis and its subsequent impact on cellular function in vitro. The effects of different LIPUS intensities on cell viability were assessed using the CCK-8 assay. Results indicated that an intensity of 40 mW/cm2 optimally maintained cell viability and significantly reversed the decrease caused by pyroptosis induction (Fig. 6a–c). Morphologically, LPS + ATP-treated cells exhibited characteristic pyroptotic swelling and rupture, which was restored to a more normal morphology by LIPUS intervention (Fig. 6e). Following PNI, SCs undergo dedifferentiation to enhance their proliferation and migration, which is critical for supporting axon regeneration and neuronal survival30. To systematically evaluate the effect of LIPUS on the behavior and function of SCs, we separately detected their survival, proliferation, and migration ability under the pyroptosis conditions model. Live/dead staining revealed that LIPUS treatment significantly increased the proportion of viable cells and effectively suppressed pyroptosis-induced cell death (Fig. 6d, g). EdU assay demonstrated enhanced SCs proliferation (Fig. 6f, g), and both Transwell and wound healing assays showed significantly improved migratory capacity with LIPUS treatment (Fig. 6h–j). In addition, we further assessed the effects of conditioned medium from different treatment groups of SCs on neuronal-like PC12 cells functionality by analyzing β-Ⅲ Tubulin expression (Fig. 6k). PC12 cells in the LIPUS-treated group exhibited longer axons (Fig. 6l, m), indicating that LIPUS indirectly promotes neuronal differentiation through suppressing SCs pyroptosis.Fig. 6LIPUS promotes the proliferation, migration, and viability of LPS + ATP-induced SCs in vitro.a Schematic diagram of LPS + ATP-induced pyroptosis in SCs and low-intensity pulsed ultrasound (LIPUS) intervention in vitro. b Cell viability measured by CCK-8 assay under varying LIPUS intensities. c CCK-8 analysis of cell viability in control, LPS + ATP, and LPS + ATP + LIPUS groups. d Cell live/death analysis in different groups. e Bright-field microscopy and cytoskeletal visualization using the actin tracker kit in different groups. The arrows indicate the swelling and rupture on the cell membrane. f, g EdU assay for proliferative activity and corresponding quantification. h–j Migration capacity assessed by wound healing and Transwell assays. n = 4 independent experiments. k Schematic diagram of conditioned medium from different treatment groups of SCs on PC12 cells. l, m Representative images and quantitative analysis of axon length following neural differentiation of PC12 cells treated with conditioned medium from different SCs groups. n = 3 independent experiments. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: PUPUTa3301). LIPUS promotes the proliferation, migration, and viability of LPS + ATP-induced SCs in vitro. a Schematic diagram of LPS + ATP-induced pyroptosis in SCs and low-intensity pulsed ultrasound (LIPUS) intervention in vitro. b Cell viability measured by CCK-8 assay under varying LIPUS intensities. c CCK-8 analysis of cell viability in control, LPS + ATP, and LPS + ATP + LIPUS groups. d Cell live/death analysis in different groups. e Bright-field microscopy and cytoskeletal visualization using the actin tracker kit in different groups. The arrows indicate the swelling and rupture on the cell membrane. f, g EdU assay for proliferative activity and corresponding quantification. h–j Migration capacity assessed by wound healing and Transwell assays. n = 4 independent experiments. k Schematic diagram of conditioned medium from different treatment groups of SCs on PC12 cells. l, m Representative images and quantitative analysis of axon length following neural differentiation of PC12 cells treated with conditioned medium from different SCs groups. n = 3 independent experiments. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: PUPUTa3301). LIPUS inhibits LPS + ATP-induced SCs pyroptosis in vitro Morphological examination by scanning electron microscopy (SEM) showed that control SCs possessed intact and smooth membranes. Upon LPS + ATP treatment, however, cells became swollen and deformed, with a conspicuous increase in membrane pores and blebs. These pyroptosis-related morphological features were largely rescued by LIPUS treatment (Fig. 7a). Pyroptosis was assessed by measuring propidium iodide (PI) uptake via flow cytometry. The results showed that LPS + ATP treatment significantly increased the proportion of PI-positive cells, and this increase was markedly attenuated by LIPUS intervention (Fig. 7b, c). Western blot analyses confirmed that LIPUS effectively reduced the protein levels of Cleaved-Caspase-1, GSDMD-N, ASC, and NLRP3, that induced by LPS + ATP (Fig. 7d–h). Immunofluorescence staining further confirmed this finding (Fig. 7i–k, m–o). Importantly, LIPUS treatment significantly reduced the number of ASC specks (Fig. 7l, p). Cell pyroptosis leads to the release of lactate dehydrogenase (LDH) from cells into the extracellular space, and the degree of cell pyroptosis can be indirectly assessed by measuring the LDH concentration in the cell culture medium9. LIPUS significantly attenuated the LPS + ATP-induced release of LDH (Fig. 7q) and the secretion of the hallmark cytokines IL-1β and IL-18, confirming its role in suppressing the pyroptotic process in SCs (Fig. 7r, s).Fig. 7LIPUS inhibits LPS + ATP-induced pyroptosis of SCs in vitro.a Cell morphology observed by scanning electron microscopy (SEM). The arrows indicate the pores and bubbles on the cell membrane. b, c Annexin V-FITC/PI staining was performed to detect pyroptosis by flow cytometry. d–h Western blotting analysis and quantitative assessment of Cleaced-Caspase-1, GSDMD-N, ASC, and NLRP3 expression in different groups. n = 3 independent experiments. i–k Immunofluorescence (IF) imaging of NLRP3, Cleaced-Caspase-1, and GSDMD-N in different groups. l Image of ASC specks (arrowheads). m–o Fluorescence intensity quantification of NLRP3, Cleaced-Caspase-1, and GSDMD-N in different groups. n = 4 independent experiments. p Percent of cells with ASC specks. q Lactate dehydrogenase (LDH) assay of cell culture supernatants. r, s Enzyme-linked immunosorbent assay (ELISA) measurement of IL-1β and IL-18 levels in supernatants. n = 3 independent experiments. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. LIPUS inhibits LPS + ATP-induced pyroptosis of SCs in vitro. a Cell morphology observed by scanning electron microscopy (SEM). The arrows indicate the pores and bubbles on the cell membrane. b, c Annexin V-FITC/PI staining was performed to detect pyroptosis by flow cytometry. d–h Western blotting analysis and quantitative assessment of Cleaced-Caspase-1, GSDMD-N, ASC, and NLRP3 expression in different groups. n = 3 independent experiments. i–k Immunofluorescence (IF) imaging of NLRP3, Cleaced-Caspase-1, and GSDMD-N in different groups. l Image of ASC specks (arrowheads). m–o Fluorescence intensity quantification of NLRP3, Cleaced-Caspase-1, and GSDMD-N in different groups. n = 4 independent experiments. p Percent of cells with ASC specks. q Lactate dehydrogenase (LDH) assay of cell culture supernatants. r, s Enzyme-linked immunosorbent assay (ELISA) measurement of IL-1β and IL-18 levels in supernatants. n = 3 independent experiments. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. LIPUS maintains mitochondrial homeostasis of LPS + ATP-induced SCs pyroptosis in vitro Detection of intracellular ROS showed a significant increase upon LPS + ATP induction, which was reduced by LIPUS treatment (Fig. 8a, b). As mitochondrial dysfunction frequently results in excessive mtROS accumulation and loss of MMP, which in turn triggers NLRP3 inflammasome activation26,27,31. We further assessed mtROS levels and MMP. After induction with LPS + ATP, the level of mtROS in SCs was elevated, accompanied by a loss of MMP. These alterations indicated mitochondrial damage and dysfunction. LIPUS intervention effectively reversed these alterations (Fig. 8c–e), suggesting its protective effect on mitochondrial function.Fig. 8LIPUS maintains mitochondrial homeostasis of LPS + ATP-induced SCs pyroptosis in vitro.a–c Intracellular and mtROS were evaluated with ROS Assay kit and Mito SOX Red. d, e Mitochondrial membrane potential (MMP) in SCs was measured by JC-1 staining to evaluate the mitochondrial activity. JC-1 aggregates indicate high MMP, while the JC-1 monomer indicates low MMP. LIPUS maintains mitochondrial homeostasis of LPS + ATP-induced SCs pyroptosis in vitro. a–c Intracellular and mtROS were evaluated with ROS Assay kit and Mito SOX Red. d, e Mitochondrial membrane potential (MMP) in SCs was measured by JC-1 staining to evaluate the mitochondrial activity. JC-1 aggregates indicate high MMP, while the JC-1 monomer indicates low MMP. Disulfiram attenuates LPS + ATP-induced SCs pyroptosis and release of inflammatory factors in vitro The pyroptosis inhibitor disulfiram suppresses pyroptosis by blocking GSDMD pore formation32. To further investigate the effect of disulfiram on LPS + ATP-induced pyroptosis in SCs, the cells were pretreated with disulfiram for 1 h before the induction of pyroptosis by LPS + ATP (Fig. 9a). Disulfiram pretreatment significantly downregulated GSDMD-N expression, pore formation (Fig. 9b–e), which was consistent with a reduction in LDH activity in the cell culture supernatant (Fig. 9f). Concurrently, disulfiram treatment markedly inhibited the release of the key pyroptosis-related inflammatory cytokines, IL-1β and IL-18. Notably, the extent of this pharmacological protection afforded by disulfiram was comparable to the protective effect observed following LIPUS intervention (Fig. 9g, h).Fig. 9Disulfiram attenuates LPS + ATP-induced SCs pyroptosis, release of inflammatory factors, and enhances axonal regeneration of PC 12 cells in vitro.a Schematic diagram of disulfiram inhibiting LPS + ATP induced pyroptosis in SCs and low-intensity pulsed ultrasound (LIPUS) intervention in vitro. b, c Western blotting analysis of GSDMD-N expression in different groups. d, e Immunofluorescence staining analysis of GSDMD-N expression in different groups. f Lactate dehydrogenase (LDH) assay of cell culture supernatants. n = 6 independent experiments. g, h Enzyme-linked immunosorbent assay (ELISA) measurement of IL-1β and IL-18 levels in supernatants. i Bright-field microscopy, cytoskeletal visualization using the actin tracker kit, and Cell live/death images in different groups. The arrows indicate the swelling and rupture of the cell membrane. j Cell live/death analysis in different groups. k EdU assay for proliferative activity and corresponding quantification. l, m Representative images and quantitative analysis of axon length following neural differentiation of PC12 cells treated with conditioned medium from different SCs groups. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: IRRRS11d11). Disulfiram attenuates LPS + ATP-induced SCs pyroptosis, release of inflammatory factors, and enhances axonal regeneration of PC 12 cells in vitro. a Schematic diagram of disulfiram inhibiting LPS + ATP induced pyroptosis in SCs and low-intensity pulsed ultrasound (LIPUS) intervention in vitro. b, c Western blotting analysis of GSDMD-N expression in different groups. d, e Immunofluorescence staining analysis of GSDMD-N expression in different groups. f Lactate dehydrogenase (LDH) assay of cell culture supernatants. n = 6 independent experiments. g, h Enzyme-linked immunosorbent assay (ELISA) measurement of IL-1β and IL-18 levels in supernatants. i Bright-field microscopy, cytoskeletal visualization using the actin tracker kit, and Cell live/death images in different groups. The arrows indicate the swelling and rupture of the cell membrane. j Cell live/death analysis in different groups. k EdU assay for proliferative activity and corresponding quantification. l, m Representative images and quantitative analysis of axon length following neural differentiation of PC12 cells treated with conditioned medium from different SCs groups. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: IRRRS11d11). Disulfiram promotes the viability of LPS + ATP-induced SCs in vitro Disulfiram markedly attenuated LPS + ATP-induced cell death, as shown by a reduced proportion of PI-positive cells in Calcein-AM/PI viability assays (Fig. 9i, j). Furthermore, EdU assays revealed that disulfiram effectively restored cell proliferation capacity to a level comparable to that achieved by LIPUS intervention, with no statistically significant difference between the two treatment groups (Fig. 9i, k). To assess the functional impact of inhibiting SCs pyroptosis on neuronal differentiation, we analyzed β-Ⅲ Tubulin expression in PC12 cells following exposure to conditioned medium from inhibitor-treated SCs. The results demonstrated that both conditioned media significantly enhanced axonal elongation in PC12 cells, with the pro-neuritic differentiation effect of disulfiram being comparable to that of LIPUS (Fig. 9l, m). Disulfiram inhibits SCs pyroptosis and reduces inflammatory cytokines after PNI in vivo To verify that GSDMD activation and the consequent SCs pyroptosis constitute a key impediment to regeneration after PNI, the specific inhibitor disulfiram was employed in vivo33. To effectively inhibit GSDMD, rats were injected once daily with disulfiram after PNI until sacrifice (Fig. 10a). At the molecular level, Western blot and immunofluorescence analyses demonstrated that disulfiram intervention significantly suppressed the expression of the GSDMD-N in SCs (Fig. 10b–e), concomitantly reducing the release of the inflammatory cytokines IL-1β and IL-18. Notably, the extent of inhibition on GSDMD-N expression and the reduction in inflammatory cytokine release were comparable between the LIPUS treatment group and the disulfiram inhibitor group, with no statistically significant difference observed between them (Fig. 10f, g).Fig. 10Disulfiram inhibits SCs pyroptosis, promotes axonal and myelin regeneration, and alleviates gastrocnemius muscle atrophy after PNI.a Schematic diagram of disulfiram injected in a rat model after PNI. b–e Disulfiram inhibits the expression of GSDMD-N was demonstrated by immunofluorescence and Western blot analysis. f, g Levels of IL-18 and IL-1β in sciatic nerve tissues across experimental groups were quantified using enzyme-linked immunosorbent assay (ELISA). h–k Representative H&E and immunohistochemistry (IHC) image of the indicators of neural regeneration in different groups at 5 dpi. l–o Representative image and quantification of muscle fiber area, diameter, and collagen volume fraction in different groups. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: RUWIA99f0e). Disulfiram inhibits SCs pyroptosis, promotes axonal and myelin regeneration, and alleviates gastrocnemius muscle atrophy after PNI. a Schematic diagram of disulfiram injected in a rat model after PNI. b–e Disulfiram inhibits the expression of GSDMD-N was demonstrated by immunofluorescence and Western blot analysis. f, g Levels of IL-18 and IL-1β in sciatic nerve tissues across experimental groups were quantified using enzyme-linked immunosorbent assay (ELISA). h–k Representative H&E and immunohistochemistry (IHC) image of the indicators of neural regeneration in different groups at 5 dpi. l–o Representative image and quantification of muscle fiber area, diameter, and collagen volume fraction in different groups. n = 6 animals. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05. The schematic diagram was drawn by Figdraw (http://www.figdraw.com/. Figdraw export ID: RUWIA99f0e). Disulfiram promotes axonal and myelin regeneration and alleviates gastrocnemius muscle atrophy after PNI We further assessed the effect of disulfiram on early nerve regeneration at 5 dpi after PNI. The results showed that disulfiram treatment significantly increased the quantity of nerve fibers and enhanced the expression of the regeneration markers NF 200 and MBP (Fig. 10h–k). Concurrently, the treatment effectively alleviated the pathological alterations in the target muscle caused by denervation. This was evidenced not only by an amelioration of muscle fiber atrophy, indicated by increases in fiber diameter and fiber area, but also by an inhibition of the fibrotic process, reflected in a reduced collagen volume fraction (Fig. 10l–o). These restorative effects achieved through pharmacological pyroptosis inhibition were comparable to the pro-regenerative efficacy of LIPUS treatment. Discussion In this study, we demonstrated that LIPUS exerts its therapeutic effects by targeting the pyroptosis cascade at multiple levels. Mechanistically, LIPUS intervention first restored mitochondrial homeostasis in SCs, as evidenced by reduced mtROS accumulation and preserved MMP. This amelioration of mitochondrial stress upstream suppressed the activation of the NLRP3 inflammasome, leading to decreased Cleaved-Caspase-1 and its downstream effector GSDMD-N. Consequently, the execution of pyroptosis was inhibited, thereby preserving SCs viability and function. Successful nerve regeneration following PNI is a complex process that critically depends on SCs. These cells guide axonal regrowth via Büngner bands and shape the regenerative microenvironment through debris clearance and neurotrophic factor secretion6,34. SCs pyroptosis has recently emerged as a major impediment to regeneration, underscoring the importance of pyroptosis inhibition8,9. As a non-invasive therapeutic modality, LIPUS exerts mechanobiological effects through acoustic wave-generated mechanical forces that modulate intracellular signaling pathways19,20. In recent years, research evidence has increasingly highlighted the therapeutic potential of LIPUS in neural regeneration. Ren et al.22 revealed LIPUS-enhanced SCs viability and proliferation via GSK-3β/β-catenin pathway activation. Wang et al.23 documented upregulated brain-derived neurotrophic factor expression accompanied by functional and histological improvements in rat sciatic crush models. Xu et al.35 reported significantly increased myelinated fiber thickness and density following LIPUS treatment. In our study, the multi-dimensional assessment substantiates LIPUS-mediated neural restoration. Morphometric analyses and SFI demonstrated superior regenerative outcomes. Critically, improvements at the neural level translated into protection of the effector organ, markedly attenuating denervation-induced gastrocnemius atrophy and fibrosis. SCs pyroptosis constitutes a programmed cell death pathway critically involved in PNI pathology8,9,36,37. Canonical pyroptosis involves NF-κB-mediated NLRP3 upregulation and pro-IL-1β and pro-IL-18 transcription, facilitating inflammasome assembly38,39. Subsequently, the NLRP3 inflammasome forms a complex with ASC and pro-caspase-1 to activate Caspase-140, which cleaves GSDMD to generate pore-forming GSDMD-N while processing inflammatory cytokines into mature IL-1β and IL-1841,42. Permeabilization of the plasma membrane by these pores disrupts osmotic balance, culminating in cell lysis and the release of inflammatory mediators43. This cascade depletes functional SCs and creates an inflammatory microenvironment that impedes regeneration13. Our data provide direct evidence of pyroptosis activation in sciatic crush models. Significant elevations in NLRP3 inflammasomes, Cleaved-Caspase-1, GSDMD-N, IL-1β, and IL-18 were observed in the PNI rat, aligning with previous reports on NLRP3 and GSDMD-mediated neural damage exacerbation29,44–46. The significant reduction in pyroptosis-related protein expression following LIPUS treatment is consistent with the observed functional neural recovery, indicating that the inhibition of this cell death pathway is a key underlying mechanism through which LIPUS promotes nerve repair. It is plausible that the reduction in pyroptosis following LIPUS treatment stems from its ability to correct aberrant inflammatory signaling within the injured nerve, thus generating a more permissive environment for regeneration47,48. Additionally, studies have shown that suppressing the expression levels of the inflammasome NLRP3 in denervated muscle tissue can effectively improve muscle atrophy49. This further suggests that LIPUS may also serve as an effective treatment for muscle atrophy. Although previous studies have reported that LIPUS reduces IL-1β and IL-18 levels in murine models of diabetic peripheral neuropathy24, it remains unclear whether LIPUS promotes nerve regeneration after PNI by alleviating SCs pyroptosis and decreasing the secretion of inflammatory cytokines. Our in vitro experiments demonstrated that LIPUS (40 mW/cm2) effectively suppressed LPS + ATP-induced pyroptosis while concurrently promoting the proliferation and migration of SCs. This is crucial for nerve regeneration, as SCs must actively proliferate and migrate to the injury site after damage to establish the structural foundation supporting axonal regeneration50,51. Furthermore, conditioned medium from LIPUS-treated SCs exhibited a markedly superior ability to promote axonal outgrowth in neuron-like PC12 cells over that from pyroptotic SCs. The LIPUS treatment not only inhibited the release of inflammatory factors but also possibly promoted the secretion of neurotrophic factors by the SCs. The dual capacity of LIPUS to simultaneously mitigate detrimental processes and promote reparative functions likely establishes a more comprehensive pro-regenerative niche, thereby facilitating both axonal elongation and target reinnervation. The persistence of myelin debris after PNI critically impedes axonal regeneration and remyelination, underscoring the necessity of its timely clearance52,53. We found that LIPUS accelerates the clearance of myelin debris by SCs. In vivo evidence from ORO and MPZ staining showed reduced myelin debris, while in vitro assessment of MBP signal decay confirmed enhanced degradation efficiency following LIPUS treatment. This process likely involves several complementary mechanisms. LIPUS-mediated suppression of pyroptosis preserves the functional SCs pool, which is essential for debris clearance, while the concomitant reduction in inflammation fosters a conducive phagocytic microenvironment. A direct potentiating effect on SCs phagocytosis via mechanotransduction may also play a role. Previous studies confirmed SCs multifaceted myelin clearance capabilities. Yuan et al.54 demonstrated that activating SCs autophagy enhances myelin debris clearance in diabetic peripheral neuropathy. While Brosius Lutz et al.3 identified that SCs clear myelin via both autophagy and TAM receptor-mediated phagocytosis. Whether LIPUS enhances myelin clearance through these or other signaling pathways remains to be elucidated. The clearance of myelin debris following PNI is orchestrated through the coordinated actions of SCs and macrophages15. Beyond its direct protective effects on SCs, LIPUS also modulated the immune landscape at the injury site. We confirmed that macrophages undergo pyroptosis during the early phase after PNI, a process that is attenuated by LIPUS intervention. Furthermore, LIPUS treatment promoted the polarization of macrophages from the M1 phenotype (pro-inflammatory) toward the M2 phenotype (anti-inflammatory) during the initial post-injury period. Although our macrophage depletion model revealed a limited contribution of these cells to direct myelin debris clearance at early phage after PNI, their presence remained essential for fostering a microenvironment conducive to subsequent nerve regeneration. This observation aligns with established temporal dynamics of debris clearance, whereby dedifferentiated SCs serve as the primary phagocytes in the immediate aftermath of injury (0–5 days)15,55. While macrophages that accumulate at the site subsequently enhance their phagocytic capacity, becoming the dominant effectors of clearance during the later stages (5–14 days)56,57. Consequently, LIPUS appears to promote nerve regeneration through a dual-pathway strategy, directly preserving SCs function by inhibiting pyroptosis while indirectly optimizing the regenerative niche through modulation of macrophage-mediated inflammation and support of their transition toward a repair-supportive phenotype. Mitochondrial dysfunction and the consequent overproduction of ROS represent key upstream events in the activation of the NLRP3 inflammasome58. Our study demonstrated that LIPUS effectively reduced mtROS levels in SCs induced by LPS + ATP and restored MMP. This suggests that LIPUS may, through its mechanobiological effects, maintain mitochondrial homeostasis, thereby suppressing the activation of the NLRP3 inflammasome. Downstream component of the NLRP3 inflammasome, GSDMD-N serves as the executioner of pyroptosis, mediating pore formation and the release of inflammatory cytokines in various pathological contexts59. To verify that GSDMD-N mediated pyroptosis is a critical barrier to nerve regeneration, we employed the specific pyroptosis inhibitor disulfiram both in vivo and in vitro, which has been confirmed to effectively inhibit GSDMD-N pore formation33. Disulfiram significantly reduced SCs pyroptosis after PNI, decreased the release of IL-1β and IL-18, and promoted nerve regeneration. Notably, the protective effects of LIPUS were comparable to those achieved with disulfiram. This congruence not only validates pyroptosis as a pivotal therapeutic target in PNI but also highlights the potential of LIPUS as a non-pharmacological, physical modality to achieve targeted molecular inhibition. The ability of LIPUS to mimic pharmacological efficacy without systemic drug exposure underscores its unique translational value as a safe and repeatable clinical intervention. This study has several limitations. Although this study provides insights using a sciatic nerve crush model, a more comprehensive evaluation of LIPUS, one that encompasses diverse injury models such as transection and systematic long-term recovery, is necessary to establish its therapeutic potential, as critically underscored in the literature60. Secondly, we confirm that LIPUS promotes nerve regeneration via the NLRP3/Caspase-1/GSDMD-N signaling axis, but its upstream regulatory mechanisms remain incompletely elucidated. Given our observation that LIPUS rapidly modulates mtROS and MMP, further studies should investigate whether mechanosensitive ion channels (such as Piezo or TRP channels) on SCs are the primary sensors translating acoustic waves into these intracellular biochemical signals. Lastly, although experiments clarified the direct effects of LIPUS on SCs in vitro, the complex multicellular interactions within the in vivo microenvironment, especially fibroblasts, endothelial cells, and molecules, require further exploration. Future studies should elucidate how LIPUS coordinates with other cellular components to synergistically promote myelin clearance and axonal regeneration at the systemic level. In summary, our study demonstrated that LIPUS alleviates SCs pyroptosis and inflammatory cytokine release following PNI by reducing mtROS levels and suppressing inflammasome activation. This inhibition preserves SCs function, enhances myelin debris clearance, proliferation, and migration, collectively fostering a regenerative microenvironment that facilitates axonal regrowth and functional recovery. These findings elucidate a mechanobiological mechanism of LIPUS and provide a critical theoretical foundation for its clinical translation in the treatment of PNI. Materials and methods Cell culture and treatment RSC 96 cells and PC12 cells (both of rat origin) were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in high-glucose Dulbecco’s Modified Eagle Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin/streptomycin (Gibco) in a humidified 5% CO2 incubator at 37 °C. SCs pyroptosis was induced as previously described9. Briefly, SCs were treated with LPS (1 μg/ml, #HY-D1056, MedChemExpress, USA) for 4 h, followed by exposure to ATP (5 mM, #HY-B2176, MedChemExpress, USA) for an additional 6 h. To investigate whether preventing pyroptosis rescues SCs function, the SCs were pretreated with the specific inhibitor disulfiram (5 μM, #HY-B0240, MedchemExpress, USA) for 1 h, which is approved by the FDA and inhibits pyroptosis by blocking GSDMD pore formation33. The SCs culture dishes were placed on an ultrasound transducer coated with an appropriate amount of ultrasound gel coupling agent. Mechanical stimulation was administered using a LIPUS device (Intelect Mobile 2, Chattanooga, USA) with parameters set to a frequency of 1 MHz, duty cycle of 20%, and treatment duration of 10 min. SCs were treated at different intensities (20, 40, 60, 80, 100, and 200 mW/cm2) for the viability assay. PC12 cells were seeded at a density of 1 × 105 cells/mL in 35 mm culture dishes. At 70% confluence, the medium was replaced with DMEM containing 1% horse serum and cultured for 24 h. Subsequently, the medium was replaced with medium containing 100 ng/mL nerve growth factor (NGF, #HY-P7660, MedChemExpress, USA) to induce neuronal differentiation for 48 h. Differentiated PC12 cells were subsequently treated with SCs-conditioned medium for 24 h. Axonal outgrowth was quantitatively assessed by measuring the length of the longest neurite. Cell viability assay Cell viability was evaluated using a CCK-8 kit (#C0038, Beyotime, China). After treatment, cells were incubated with CCK-8 reagent for 2 h at 37 °C, and the absorbance at 450 nm was measured using a microplate reader (Thermo Fisher Scientific, USA). The assay was used concurrently to determine the optimal LIPUS intensity and to examine the effect of optimal LIPUS on cell viability following LPS + ATP-induced pyroptosis. Cell proliferation assay SCs were seeded in 35 mm dishes at 5 × 104 cells per well. Following LIPUS treatment, cell proliferation was assessed using an EdU assay kit (#C0071, Beyotime, China) according to the manufacturer’s protocol. Briefly, cells were incubated with 50 μmol/L EdU in serum-free DMEM for 2 h at 37 °C. Subsequently, cells were fixed with 4% paraformaldehyde (PFA) and permeabilized with 0.5% Triton X-100 in PBS. EdU incorporation was visualized and imaged using fluorescence microscopy (Leica, Germany). Calcein-AM/PI staining Cell cytotoxicity was assessed using a Calcein-AM/PI Double Staining kit (#C2015, Beyotime, China) according to the manufacturer’s instructions. Stained cells were imaged under a fluorescence microscope (Leica, Germany). Transwell migration assay Transwell chambers (#FTW043-12Ins, Beyotime, China) with 8 μm pore size were used in this study. Cells were suspended in serum-free medium and seeded into the upper chamber at a density of 2 × 104 cells/well. The lower chamber contained 500 μL DMEM supplemented with 10% FBS as a chemoattractant. After 24 h incubation at 37 °C with 5% CO2, non-migrated cells on the upper membrane surface were gently removed using cotton swabs. Migrated cells on the lower surface were fixed with 4% PFA for 10 min and stained with 0.1% crystal violet (#Y268091, Beyotime, China) for 20 min. Following PBS washes, imaging was performed using a microscope (Leica, Germany), and migrating cells were subjected to quantitative analysis. Wound healing assay A wound healing assay was performed with SCs plated in 96-well plates at a density of 2 × 105 cells per well. After the cells reached confluence, a linear scratch was generated in the monolayer using a sterile 200 μL pipette tip. Following the creation of the scratch and removal of detached cells by PBS washing, basal medium was added. Images were captured at 0 h and 24 h post-scratching, respectively. The rate of wound closure was quantified by comparing the residual wound area at 24 h to the initial area at 0 h using ImageJ software (National Institutes of Health, USA). Flow cytometry Pyroptosis was assessed by flow cytometry using an Annexin V-FITC/PI apoptosis detection kit (#C1062, Beyotime, China). Briefly, cells from different treatment groups were harvested, washed twice with PBS, and resuspended in binding buffer to obtain a single-cell suspension. For staining, 5 µL of Annexin V-FITC and 10 µL of PI were sequentially added to the cell suspension. After gentle mixing, the cells were incubated at room temperature in the dark for 10 min. Subsequently, 400 µL of 1× binding buffer was added, and the samples were immediately analyzed. Data acquisition was performed on a BD Fortessa flow cytometer (BD Biosciences, USA), and the results were analyzed using FlowJo software. Scanning electron microscope The morphological features of cells across intervention groups were examined using a scanning electron microscope (SEM) (ZEISS, Germany). Cell samples were freeze-dried for 24 h, cryofractured in liquid nitrogen to expose cross-sections, sputter-coated with gold, and imaged under SEM at an accelerating voltage of 15 kV. SCs clear myelin debris in vitro Myelin debris was prepared from adult SD rat brain tissue according to established protocols61. Briefly, dissected brain tissue was minced with ophthalmic scissors and homogenized in PBS containing 0.27 M sucrose. The homogenate was centrifuged to pellet myelin debris at the tube bottom. The collected myelin debris was added to the SCs dish and incubated for 24 h. Residual myelin debris was removed by washing with PBS, followed by LIPUS treatment. The samples were then incubated at 37 °C with 5% CO2 for 12 h, 24 h, and 48 h, respectively, followed by immunofluorescence analysis. LDH assay Supernatants from all treatment groups were collected and analyzed using the LDH Cytotoxicity Assay kit (#C0017, Beyotime, China) following the manufacturer’s instructions. Briefly, a new 96-well plates were incubated with Lysis Buffer for 1 h to establish maximum LDH release. At designated timepoints, 120 μL of supernatant from each group was transferred to 96-well plates, followed by the addition of 60 μL LDH working solution per well. After 30-min incubation at room temperature, absorbance at 490 nm was measured using a microplate reader (Thermo Fisher Scientific, USA). Enzyme-linked immunosorbent assay The concentrations of IL-18 (#E-EL-R0567, Elabscience, China) and IL-1β (#E-ELR0012, Elabscience, China) in cell-conditioned medium were quantified using ELISA kits following the manufacturer’s instructions. Sciatic nerve tissues from different intervention groups were homogenized and centrifuged to obtain supernatants for cytokine measurement. Optical density values were analyzed using a microplate reader (Thermo Fisher Scientific, USA), with intergroup differences statistically evaluated. Intracellular ROS detection Cellular ROS levels were measured using a fluorescent ROS Assay kit (#S0033, Beyotime, China). Briefly, after treatment with LPS + ATP, cells were incubated with 10 µM DCFH-DA at 37 °C for 30 min. To thoroughly remove any extracellular DCFH-DA probe that had not diffused into the cells, the cells were then washed three times with serum-free culture medium. Finally, fluorescence images were acquired using a fluorescence microscope (Leica, Germany). Mitochondrial ROS detection Mitochondrial ROS (mtROS) levels were measured using MitoSOX™ Red (#S0061, Beyotime, China). Briefly, SCs were incubated with 1 µM MitoSOX Red working solution at 37 °C for 30 min. After incubation, the cells were washed twice with PBS to remove excess probe. Subsequently, the cells were observed and imaged under a fluorescence microscope (Leica, Germany). Detection of mitochondrial membrane potential Cells seeded in culture dishes were stained using the Mitochondrial Membrane Potential Assay kit (#C2006, Beyotime, China). Briefly, the staining working solution from the kit was applied to the cells, followed by incubation at 37 °C for 30 min. Subsequently, the culture medium was removed, and the cells were gently washed twice with Hanks’ Balanced Salt Solution. After adding the imaging buffer provided with the kit, the cells were immediately observed and imaged under a fluorescence microscope (Leica, Germany). Establishment and treatment of the rat PNI model Adult male Sprague-Dawley rats (8 weeks old, 200–250 g) were supplied by Slaccas Experimental Animal Co., Ltd. (Shanghai, China). Before surgery, animals were fasted for 6 h and anesthetized via isoflurane inhalation. The right hindlimb was shaved and sterilized. A posterolateral longitudinal incision was made in the femoral region, and the sciatic nerve was exposed approximately 1 cm distal to the sciatic notch by blunt dissection between the gluteus maximus and biceps femoris muscles. A hemostatic forceps was used to clamp the nerve for 2 min, resulting in an injury zone of about 2 mm15. Postoperative closure was achieved using 6-0 sutures to approximate the muscle fascia and skin layers. All animals were housed under standard conditions with free access to food and water. All animal experimental procedures and protocols were approved by the Animal Ethics Committee of Shanghai Jiao Tong University (Approved No. 2024003). We have complied with all relevant ethical regulations for animal use. On the first day after PNI, the rats in the LIPUS group received daily ultrasound therapy at the injury site for 10 min at a frequency of 1 MHz and a duty cycle adjusted to 20%. Ultrasound waves undergo significant signal attenuation when penetrating tissues such as skin and muscle in vivo. Consequently, a higher acoustic intensity was required to ensure that energy reaches the deeper sciatic nerve and remains within a biologically effective range. In this study, an intensity of 200 mW/cm2 was selected for LIPUS treatment. This parameter is widely adopted and validated for promoting nerve regeneration and functional recovery62,63. Euthanasia was performed at 5 dpi and 14 dpi. To investigate the role of macrophages in the clearance of myelin debris at 5 dpi, an in vivo rat model of specific macrophage depletion was used by administering clodronate liposomes (CL). It is well established that CL administration effectively depletes macrophages within 24 h, with repopulation beginning approximately 72 h after injection64,65. In our study, clodronate liposomes (25 mg/kg, #40337ES10, YEASEN, China) were administered before sciatic nerve crush injury and subsequently every 2 days until sacrifice66,67. Control rats received liposomes containing PBS only (25 mg/kg, #40338ES10, YEASEN, China) to control for potential nonspecific effects of CL injection. In addition, to further examine whether LIPUS promotes myelin formation and axonal regeneration by inhibiting pyroptosis and restoring SCs function, the specific pyroptosis inhibitor disulfiram (50 mg/kg, #HY-B0240, MedchemExpress, USA) was administered intraperitoneally from 1 to 5 dpi32. Gait analysis The SFI was used to assess the recovery of gait in rats at 5 dpi, 7 dpi, and 14 dpi. The hind paws of the rats were painted with red ink, and the rats were allowed to walk through a narrow corridor to leave footprints on white paper. SFI was calculated as previously reported9. Histological staining A total of 1 cm segment of sciatic nerve tissue from the injury site to the distal region was harvested at 5 dpi and 14 dpi. For histological analysis, 2 mm segments within the damaged lesion were sectioned at 5 μm thickness slices. These sections were then stained following the manufacturer’s instructions with Hematoxylin and Eosin (HE, #C0105, Beyotime, China), Masson’s Trichrome (#C0189, Beyotime, China), and Luxol Fast Blue (LFB, #G3240, Solarbio, China) (Fig. 2A). All stained specimens were imaged using an optical microscope (Leica, Germany). ORO staining Following longitudinal cryosectioning of sciatic nerve tissues, sections were fixed in 4% PFA for 20 min. After three washes with PBS, tissues were dehydrated in 100% propylene glycol for 10 min and stained with 0.5% ORO (#G1260, Solarbio, China) for 10 min. Nuclei were counterstained with hematoxylin (#C0105, Beyotime, China) for 5 min. Images of myelin fragment-positive areas were acquired using an optical microscope (Leica, Germany). Immunofluorescence staining For tissue immunofluorescence staining, sciatic nerve tissues were fixed in 4% PFA for 24 h, followed by paraffin embedding and sectioning. After dewaxing and permeabilization, sections were blocked with 5% bovine serum albumin (BSA) for 1 h at room temperature. Subsequently, the tissue sections were incubated overnight at 4 °C with the following primary antibodies NF 200 (1:400, #60331-1-Ig, Proteintech, China), MBP (1:200, #ab7349, Abcam, USA), S100 (1:200, #90393, Cell Signaling Technology, USA), MPZ (1:100, #ab183868, Abcam, USA), GFAP (1:2000, #ab7260, Abcam, USA), GSDMD-N (1:400, #HY-P86158, MedChemExpress, USA), and NLRP3 (1:200, #MA5-32255, Thermo Fisher, USA). After washing with PBS, the sections were incubated with fluorescent secondary antibodies (1:400, Servicebio, China) for 1 h at room temperature. Finally, nuclei were counterstained with 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI, #C1006, Beyotime, China) for 5 min, and the sections were mounted and imaged under a fluorescence microscope (Leica, Germany). For cell immunofluorescence, cells seeded on coverslips were fixed with 4% PFA at room temperature for 10 min, permeabilized with Triton X-100 for 10 min, and then blocked with 5% BSA for 1 h to minimize non-specific binding. Cells were incubated overnight at 4 °C with primary antibodies MBP (1:200, #ab7349, Abcam, USA), GSDMD-N (1:500, #HY-P86158, MedChemExpress, USA), Cleaved-Caspase-1 (1:200, #HY-P80622, MedChemExpress, USA), NLRP3 (1:200, #MA5-32255, Thermo Fisher, USA), ASC (1:200, #340097, Zen Bioscience, China), MBP (1:200, #ab7349, Abcam, USA), and β-Ⅲ Tubulin (1:200, #5568, Cell Signaling Technology, USA). After washing 3 times with PBS, the cells were incubated with fluorescent secondary antibody (1:400, Servicebio, China) for 1 h. After staining nuclei with DAPI, images were captured using microscopy parameters (Leica, Germany). Immunohistochemical staining Immunohistochemical analysis was performed according to the manufacturer’s instructions. Paraffin sections were deparaffinized with xylene, rehydrated with ethanol, and then placed in a reconditioning box filled with EDTA antigen retrieval buffer for antigen retrieval. After washing, sections were blocked with 5% BSA for 30 min at room temperature. Subsequently, sections were incubated overnight at 4 °C in a humid chamber with the primary antibodies NF 200 (1:4000, #60331-1-Ig, Proteintech, China), MBP (1:4000, #ab7349, Abcam, USA), CD68 (1:500, #83014-5-RR, Proteintech, China), CD86 (1:800, #26903-1-AP, Proteintech, China), and CD206 (1:2000, #18704-1-AP, Proteintech, China). The next day, sections were incubated with secondary antibodies at room temperature for 1 h. Following washing, nuclei were stained with DAPI for 10 min prior to imaging. RNA sequencing We performed RNA sequencing analysis on sciatic nerve tissue from rats in the PNI model and LIPUS treatment model at 5 dpi. Total RNA was isolated from sciatic nerve tissues using Trizol reagent following the manufacturer’s protocol. Libraries were constructed and sequenced using standard Illumina protocols. Gene expression quantification was performed using the Fragments Per Kilobase of transcript per Million mapped reads (FPKM) method. Functional enrichment analysis was conducted through GO assessments using the IGE bioinformatics platform. Western blotting The tissues and cell samples were lysed in Laemmli sample buffer. Protein concentrations of the lysates were quantified using a BCA Protein Assay kit (#P0011, Beyotime, China). Total protein samples were separated by SDS-PAGE and transferred onto PVDF membranes. After blocking with 5% skim milk, the membranes were incubated overnight at 4 °C with the primary antibodies GSDMD-N (1:2000, #HY-P86158, MedChemExpress, USA), Cleaved-Caspase-1 (1:1000, #HY-P80622, MedChemExpress, USA), NLRP3 (1:1000, #MA5-32255, Thermo Fisher, USA), and ASC (1:1000, #340097, Zen Bioscience, China). β-actin (1:1000, #3975, Cell Signaling Technology, USA) was used as the loading control. Then, the PVDF membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:1000, Beyotime, China) for 1 h at room temperature. After secondary antibody incubation, protein bands were visualized using an enhanced chemiluminescence kit (ECL, # 36222ES60, YEASEN, China) and quantified through densitometric analysis using ImageJ software. Statistical analysis Statistical analyses were performed using GraphPad Prism 9.5.0 (GraphPad Software, USA). Intergroup differences were assessed by one-way ANOVA and Student’s t test. A significance threshold of P < 0.05 was applied for all statistical inferences. All experiments were independently repeated at least three times. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Transparent Peer Review File Supplementary Information Description of Additional Supplementary Files Dataset 1 Reporting summary Transparent Peer Review File Supplementary Information Description of Additional Supplementary Files Dataset 1 Reporting summary